MORGAN STANLEY - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 24 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q3 2023$975
-38.2%
5330.0%0.00%
Q2 2023$1,578
+6.9%
5330.0%0.00%
Q1 2023$1,476
-46.8%
5330.0%0.00%
Q4 2022$2,777
+38.8%
5330.0%0.00%
Q3 2022$2,000
-66.7%
533
-67.4%
0.00%
Q2 2022$6,000
-70.0%
1,633
-57.5%
0.00%
Q1 2022$20,000
-4.8%
3,8430.0%0.00%
Q4 2021$21,000
-12.5%
3,8430.0%0.00%
Q3 2021$24,000
+33.3%
3,843
+20.3%
0.00%
Q2 2021$18,000
-92.2%
3,195
-86.5%
0.00%
Q1 2021$232,000
+648.4%
23,660
+1026.7%
0.00%
Q4 2020$31,0002,1000.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 1,058,035$2,9310.15%
Gradient Capital Advisors, LLC 26,808$74,2580.03%
WEST PACES ADVISORS INC. 1,665$4,6120.00%
DIMENSIONAL FUND ADVISORS LP 28,652$79,3660.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 17,484$48,4300.00%
CITIGROUP INC 7$190.00%
MORGAN STANLEY 533$1,4760.00%
NATIONAL BANK OF CANADA /FI/ 2,255$6,2510.00%
WOLVERINE TRADING, LLC 11,700$330.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders